跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 376 条关于
“PDP1”
全部
376
临床试验
277
药物
82
机构
0
资讯
17
5个月前
Quizartinib Combination Therapy Shows Promise in Phase II Trial for FLT3-ITD AML
去年
CDK1 and TDP1 Inhibition Synergistically Overcomes Cancer Drug Resistance
6个月前
Melodia Therapeutics Secures Key U.S. Patent for Novel DPP1 Inhibitor MLD-151
2年前
Replimune's RP1 Shows Durable Responses in Anti-PD1 Failed Melanoma
去年
Anti-PD1 Precision Therapy Shows Promise in Unresectable Stage III NSCLC Trial
上个月
Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial
11个月前
Expedition Therapeutics Secures $165 Million Series A to Advance First-in-Class DPP1 Inhibitor for COPD
去年
Replimune's RP1 Plus Nivolumab Shows Promise in Anti-PD1 Failed Melanoma
去年
Replimune's RP1 Plus Nivolumab Shows Promise in Anti-PD1 Failed Melanoma
去年
Replimune's RP1 Plus Nivolumab Shows Promising Results in Anti-PD1 Failed Melanoma
第 1 页,共 2 页
上一页
下一页